Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23191841 | 0.81 | DGAT1 (0.35) | DGAT1AAK1HDAC6HDAC1HDAC2 | |
| SCHEMBL5345861 | 0.80 | AAK1 (0.35) | DGAT1AAK1HDAC6HDAC1HDAC2 | |
| SCHEMBL643632 | 0.78 | AAK1 (0.35) | DGAT1AAK1HDAC6HDAC1HDAC2 | |
| SCHEMBL8865890 | 0.78 | SMN1; SMN2 (0.31) | — | |
| SCHEMBL9455522 | 0.78 | CA14 (0.41) | DGAT1AAK1HDAC6HDAC1HDAC2 | |
| SCHEMBL18796420 | 0.78 | CA14 (0.41) | DGAT1AAK1HDAC6HDAC1HDAC2 | |
| SCHEMBL7021061 | 0.78 | CA14 (0.41) | DGAT1AAK1HDAC6HDAC1HDAC2 | |
| SCHEMBL18885732 | 0.77 | AAK1 (0.34) | DGAT1AAK1HDAC6HDAC1HDAC2 | |
| SCHEMBL21964901 | 0.77 | CA1 (0.35) | DGAT1AAK1HDAC6HDAC1HDAC2 | |
| SCHEMBL4794923 | 0.77 | AAK1 (0.34) | DGAT1AAK1HDAC6HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2996685-B1 | ANTI-INFLUENZA COMPOSITIONS AND METHODS | BIOCRYST PHARM INC (US) | 2019-03-27 | — | — | EP | disclosed |